Neurodegenerative and neuroinflammatory diseases rarely follow a simple path. They often involve changes in brain wiring, immune activity, cellular stress, and protective responses that may look different depending on the condition. In frontotemporal dementia, one study shows that altered amygdala connectivity may help explain changes in empathy and emotion recognition, with different patterns appearing across disease subtypes. In multiple sclerosis, another paper highlights opioid signaling as a possible therapeutic target, with early evidence suggesting it may influence inflammation, myelin repair, and neuron protection.
The Alzheimer’s mouse model study adds another important layer by challenging the assumption that amyloid plaques are always harmful. In this model, plaques appeared to reduce memory problems and protect hippocampal neurons, possibly by buffering more toxic soluble forms of amyloid. Together, these papers point to a broader theme: the nervous system’s response to disease is complex, and future therapies may need to target not only damage itself, but also the circuits, immune signals, and protective mechanisms that shape how disease progresses.
1. Altered amygdala structural connectivity and relations to social cognition in frontotemporal dementia
Altered amygdala connectivity differed across frontotemporal dementia subtypes and was linked to social cognition changes. In bvFTD and semantic dementia, distinct disrupted pathways related to empathy and emotion recognition deficits.
2. Opioid Signaling in Multiple Sclerosis: Emerging Targets for Repair
Opioid signaling may offer new ways to support MS care by modulating inflammation, promoting remyelination, and protecting neurons. Strategies targeting KOR, OGF/OGFr, and low-dose naltrexone show early promise, though stronger clinical evidence is still needed.
3. Amyloid Plaques Ameliorate Memory Deficits and Hippocampal Neuron Loss in an Aβ4-42-Driven Alzheimer’s Disease Mouse Model
In an Alzheimer’s mouse model, amyloid plaques did not worsen memory loss and appeared to improve recognition memory while reducing neuron loss in part of the hippocampus. The findings support the idea that plaques may help buffer toxic soluble Aβ species early in disease.
If you’d like to stay informed of the latest publications and breakthroughs in neuron regeneration, join our email newsletter to the right (or below on mobile). We send out weekly updates with the latest papers and studies, as well as podcast episodes with the people driving Neuroregenerative breakthroughs.
